Related Experiment Video
Updated: Sep 9, 2025
08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
7.6K
Histone modifications: Key players in Alzheimer's disease
Kun Li1, Xiaolin Qiu2, Qiqi Yang2
1Department of Nuclear Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 250014, China.
Mechanisms of Ageing and Development
|September 4, 2025
Summary
Histone modifications like acetylation, crotonylation, and lactylation are key in Alzheimer's disease (AD) pathology. Targeting these modifications offers a promising new avenue for AD treatment.
Area of Science:
- Neuroscience
- Epigenetics
- Biochemistry
Background:
- Alzheimer's disease (AD) is a leading cause of cognitive decline in the elderly.
- Current treatments for AD are insufficient to halt disease progression.
- Novel biomarkers and therapeutic targets for AD are critically needed.
Purpose of the Study:
- To review the role of histone modifications in Alzheimer's disease pathogenesis.
- To explore the association between histone modifications and AD hallmarks.
- To evaluate histone-modifying enzymes as potential therapeutic targets for AD.
Main Methods:
- Literature review of existing studies on histone modifications and AD.
- Analysis of the link between histone modifications and amyloid beta accumulation.
- Examination of the connection between histone modifications and Tau protein hyperphosphorylation.
Main Results:
- Histone acetylation, crotonylation, and lactylation are implicated in AD pathology.
- These modifications correlate with amyloid plaques and Tau tangles.
- Histone modifications are associated with neuroinflammation and synaptic dysfunction.
Conclusions:
- Histone modifications play a central role in the pathogenesis of Alzheimer's disease.
- Histone-modifying enzymes represent promising therapeutic targets for AD treatment.
- Further research into epigenetic mechanisms could unlock new AD therapies.
Related Concept Videos
02:25Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
02:32Histone Modification
13.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.8K
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
02:30Histone Variants at the Centromere
4.5K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.5K
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:32Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K